Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Pomalidomide
Drug ID BADD_D01798
Description Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.
Indications and Usage Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Marketing Status approved
ATC Code L04AX06
DrugBank ID DB08910
KEGG ID D08976
MeSH ID C467566
PubChem ID 134780
TTD Drug ID D0A3ZU
NDC Product Code 65015-893; 17337-0068; 63069-404; 68554-0092; 70225-1106; 59572-501; 59572-502; 55111-989; 68554-0091; 82245-0108; 63069-402; 42973-232; 54893-0038; 59572-503; 59572-504; 63069-403
UNII D2UX06XLB5
Synonyms pomalidomide | CC-4047 | CC 4047 | CC4047 | Imnovid | Pomalyst | actimid
Chemical Information
Molecular Formula C13H11N3O4
CAS Registry Number 19171-19-8
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Plasma cell leukaemia01.14.02.003; 16.23.02.0030.001567%-
Plasma cell myeloma01.14.02.004; 16.23.02.0040.406275%-
Plasmacytoma01.14.02.002; 16.23.02.0020.007450%-
Platelet count decreased13.01.04.001--
Platelet disorder01.08.03.0010.002532%-
Pneumonia11.01.09.003; 22.07.01.003---
Pneumonia respiratory syncytial viral11.05.13.002; 22.07.05.005---
Pneumonia streptococcal11.02.06.005; 22.07.06.006---
Pollakiuria20.02.02.0070.013575%
Poor peripheral circulation24.04.03.0130.001712%-
Post herpetic neuralgia11.07.01.010; 17.02.07.0140.000241%-
Productive cough22.02.03.005--
Prostatic disorder21.04.01.0010.001495%-
Pruritus23.03.12.0010.134782%
Pulmonary embolism22.06.02.001; 24.01.06.001---
Pulmonary oedema02.05.02.003; 22.01.03.0030.006872%
Pulmonary thrombosis22.06.02.003; 24.01.06.0020.007716%-
Pyrexia08.05.02.0030.093986%
Rash23.03.13.0010.260426%-
Rash macular23.03.13.0030.009283%-
Rash pruritic23.03.13.0300.028283%-
Raynaud's phenomenon24.04.03.0030.001881%-
Rectal prolapse07.03.01.0050.000241%-
Renal disorder20.01.02.0020.031730%-
Renal failure20.01.03.0050.025196%-
Renal pain20.02.03.0030.003231%-
Respiration abnormal22.02.01.0410.005425%-
Respiratory disorder22.02.07.0020.012538%-
Respiratory failure14.01.04.003; 22.02.06.002--
Retinal disorder06.08.03.0050.000482%-
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 16 Pages